- The power and limitations of immunobridging studies: the example of COVID-19 vaccines
- HPV vaccination: Prospect of moving to a one and only dose schedule
- Safety of COVID-19 Vaccines
- Will the success of mRNA vaccine development platforms for COVID-19 lead to new platforms for old vaccines?
- COVID vaccines: is there a need for boosters in view of the emergence of variants and waning immunity? (S4)
- COVID vaccines: is there a need for boosters in view of the emergence of variants and waning immunity? (S3)
- COVID vaccines: is there a need for boosters in view of the emergence of variants and waning immunity? (S2)
- COVID vaccines: is there a need for boosters in view of the emergence of variants and waning immunity? (S1)
- The impact of COVID-19 on the immunization programmes and how to correct the situation.
- Logistics of deployment of COVID vaccines on a global level
